# Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane

> **NCT02104791** · — · UNKNOWN · sponsor: **Ain Shams Maternity Hospital** · enrollment: 100 (actual)

## Conditions studied

- Intra-amniotic Subclinical Infection.

## Interventions

- **DRUG:** procalcitonin

## Key facts

- **NCT ID:** NCT02104791
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104791, "Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02104791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*